The distribution of symptoms of attention-deficit/hyperactivity disorder and oppositional defiant disorder in school age children in Turkey

2004 ◽  
Vol 13 (6) ◽  
pp. 354-361 ◽  
Author(s):  
E. Erdal Erşan ◽  
Orhan Doğan ◽  
Selma Doğan ◽  
Haldun Sümer
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Oppositional Defiant Disorder ◽  
Attention Deficit ◽  
School Age Children ◽  
School Age ◽  
Hyperactivity Disorder ◽  
Oppositional Defiant

Oppositional Defiant Disorder and Its Clinical Management

2017 ◽  
Author(s):  
Paul Croarkin ◽  
Reem Shafi
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Conduct Disorder ◽  
Oppositional Defiant Disorder ◽  
Treatment Planning ◽  
Attention Deficit ◽  
Hyperactivity Disorder ◽  
Disruptive Mood Dysregulation Disorder ◽  
Dsm 5 ◽  
Oppositional Defiant ◽  
Mood Dysregulation

Oppositional defiant disorder (ODD) is a psychiatric disorder classified in the DSM-5 among disruptive, impulse control, and conduct disorder. The core features of ODD include a pervasive and impairing pattern of anger, irritability, inflexibility, defiance, malevolence, and aggression. Symptoms of ODD typically present during preschool. ODD can be a harbinger of conduct disorder. Isolated, transient symptoms of ODD are normal during development. Mood disorders, attention-deficit/hyperactivity disorder, and neurodevelopmental disorders are important considerations in differential diagnosis. However, ODD frequently co-occurs with other psychiatric diagnoses. Complex interactions with temperamental emotional dysregulation, family stress, early life stress, inconsistent parenting, and genetic and physiologic factors likely underlie the risk, pathophysiology, and prognosis of ODD. Unfortunately, these interactions and the neurobiological underpinnings of ODD are still poorly characterized. Although first-line treatments for ODD involve behavioral and psychosocial interventions, a thoughtful consideration of pharmacotherapy for co-occurring disorders and severe symptoms is an important component of treatment planning. Herein we review the epidemiology, etiology, pathophysiology, diagnostic evaluation, and treatment planning of ODD. Recent applicable controversies such as dimensional conceptualization of psychiatric disorders and the potential intersection of ODD and disruptive mood dysregulation disorder are also summarized.  This review contains 5 figures, 4 tables, and 44 references. Key words: aggression, attention-deficit/hyperactivity disorder, conduct disorder, defiance, disruptive behaviors, disruptive mood dysregulation disorder, DSM-5, irritability, oppositional defiant disorder, parent management training

scholarly journals Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders

2012 ◽  
Vol 12 (3) ◽  
pp. 28-38
Author(s):  
E. Snircova ◽  
T. Kulhan ◽  
G. Nosalova ◽  
I. Ondrejka
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Oppositional Defiant Disorder ◽  
Attention Deficit ◽  
High Rate ◽  
Response To Treatment ◽  
Psychosocial Impairment ◽  
Hyperactivity Disorder ◽  
Oppositional Defiant ◽  
Co Morbidity ◽  
Psychiatric Problems

Abstract Attention-deficit/hyperactivity disorder (ADHD) in childhood or adolescence is associated with a significantly higher lifetime risk of oppositional defiant disorder, anxiety disorder, conduct disorder, among others. Reports of co-morbidity rates are variable and influenced by assesment methodology and refferal bias, and may reflect lifetime rates within clinical groups. Up-to date studies revealed that as many as 85% of patients with ADHD have at least one psychiatric comorbidity and approximately 60% have at least two. Research and clinical practice has shown that having multiple co-existing psychiatric problems increase the severity of ADHD and behavioural problems, and is associated with incereased psychosocial impairment. The high rate of psychiatric problems co-occuring with ADHD has strong implications for the management of these patients. The presence of co-existing psychiatric conditions may moderate the response to treatment of ADHD and ADHD treatments may adversely affect and exacerbate the symptoms of the co-morbit condition. The aim of this article was to summarize the use of atomoxetine in the most frequent co-morbid disorders accompaining ADHD, ODD (oppositional defiant disorder) and anxiety, and to emphazise decrease of co-morbid symptoms with treatment of atomoxetine what exhort us to think about them as about possible subtypes of ADHD.

Sign in / Sign up

Export Citation Format

Share Document